Kristen K. Buck - Jan 9, 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
EVP, R&D and CMO
Signature
James Nisco, Attorney-in-Fact for Kristen K. Buck
Stock symbol
LSTA
Transactions as of
Jan 9, 2023
Transactions value $
-$8,077
Form type
4
Date filed
1/11/2023, 03:03 PM
Previous filing
Sep 2, 2022
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +18K +87.88% $0.00 38.5K Jan 9, 2023 Direct F1, F2
transaction LSTA Common Stock Tax liability -$6.44K -2.15K -5.58% $3.00 36.3K Jan 9, 2023 Direct F2, F3
transaction LSTA Common Stock Tax liability -$1.64K -512 -1.41% $3.20 35.8K Jan 10, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LSTA Stock Options (Right to Buy) Award $0 +9K $0.00 9K Jan 9, 2023 Common Stock 9K $3.00 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 18,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
F2 Includes 23,808 unvested restricted stock awards.
F3 Shares withheld as payment of a tax liability on vesting of restricted stock.
F4 Includes 22,733 unvested restricted stock awards.
F5 One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.